A pharmacogenetics test can help your prescriber understand how your body is likely to process ADHD medicines and many others. Below, we cover the basics of ADHD treatment and then walk through the test itself, from the cheek swab to reading your report and using it safely.
On this page
Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions in the United States. According to the CDC, approximately 6 million children between the ages of 3–17 have been diagnosed with ADHD, while millions of adults also live with this condition. Treating ADHD effectively often involves trial and error with various medications and dosages, leading to prolonged discomfort for patients as they wait to see which treatment works best for them. Pharmacogenetics tests give insights into your genetic makeup, helping doctors to prescribe the medications that suit your unique DNA.
Key Takeaways
- What is a Pharmacogenetics Test?
- Does Adderall Treat ADHD?
- Common Medications Used to Treat ADHD
- How Does a Pharmacogenetics Test Benefit ADHD Treatment?
What is a Pharmacogenetics (PGx) Test?
A pharmacogenetics test analyzes an individual’s genetic profile to predict their response to certain medications. This field of study emerged in the mid-20th century, and its role in healthcare continues to grow. By examining variations in genes that affect drug metabolism, doctors can consider which medications and doses are more likely to suit a patient, which may help reduce side effects and improve outcomes.
Pharmacogenetics is particularly beneficial for mental health conditions like ADHD, where individual responses to medications vary significantly. The test is non-invasive, typically requiring a simple cheek (buccal) swab, making it simple and convenient for patients of all ages.
Potential Benefits of Pharmacogenetics Testing
- Reduced Trial and Error: Instead of experimenting with various medications, doctors can choose drugs that are more likely to be effective based on genetic results.
- Tailored Dosing: The test helps determine whether a patient metabolizes a drug quickly, normally, or slowly, enabling doctors to adjust doses accordingly.
- Minimized Side Effects: When your prescriber can factor in your genetic makeup, the risk of some adverse effects may be reduced.
Does Adderall Treat ADHD?
Yes, Adderall, a combination of dextroamphetamine and amphetamine, is one of the most commonly prescribed medications for ADHD. It works by increasing the availability of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which help improve attention and reduce impulsivity.
However, Adderall may not be suitable for everyone due to differences in how individuals metabolize amphetamines. Pharmacogenetics testing can add useful information here, for example by showing CYP2D6 metabolizer status, which your doctor can weigh alongside your symptoms and history when choosing between Adderall and other medications.
Common Medications Used to Treat ADHD
The FDA-approved medications for ADHD fall into two main categories:
Stimulants
Stimulants work by primarily increasing the levels of two key brain chemicals (neurotransmitters), Dopamine and Norepinephrine. Dopamine plays a crucial role in focus, motivation, and reward. While, Norepinephrine helps with attention, alertness, and arousal.
Stimulants are considered first-line treatments for ADHD because they effectively increase focus and control impulsive behavior. The following are common prescription stimulants used to treat ADHD:
Adderall (Amphetamine/Dextroamphetamine)
Dosage: 5 mg to 40 mg per day, split into 1 to 3 doses.
Duration of Action: Immediate-release Adderall typically lasts about 4 to 6 hours per dose.
Ritalin (Methylphenidate)
Dosage: 5 mg to 20 mg (taken 2–3 times daily).
Duration of Action: Immediate-release Ritalin generally lasts about 3 to 4 hours per dose.
Vyvanse (Lisdexamfetamine)
Dosage: 10 mg to 70 mg (once daily).
Duration of Action: Vyvanse is designed to last approximately 10 to 13 hours per dose.
Non-Stimulants
Non-stimulants work differently from stimulants. Atomoxetine (Strattera) and viloxazine (Qelbree) mainly increase norepinephrine, while guanfacine (Intuniv) and clonidine (Kapvay) are alpha-2 adrenergic agonists that act on receptors in the prefrontal cortex. These medications have a lower potential for misuse or dependence.
Non-stimulants are often prescribed when stimulant medications are not effective or cause significant side effects. Following are some of the common non-stimulant medications:
Strattera (Atomoxetine)
Dosage: 40 mg to 100 mg (once or twice daily).
Duration of action: Up to 24 hours
Intuniv (Guanfacine ER)
Dosage: 1 mg to 4 mg (once daily).
Duration of action: Up to 24 hours
Kapvay (Clonidine ER)
Dosage: 0.1 mg to 0.4 mg per day (usually split into two doses).
Duration of action: Taken twice daily for all-day coverage
How Does a Pharmacogenetics Test Benefit ADHD Treatment?
When you take medication, your body metabolizes it using specific enzymes. Some people have genetic variations that make these enzymes work faster or slower than normal, affecting how the drug is absorbed, distributed, and eliminated from the body. For example:
- Rapid Metabolizers: They may break down a drug too quickly, resulting in lower efficacy.
- Poor Metabolizers: They may metabolize a drug too slowly, leading to increased side effects.
- Normal Metabolizers: They process drugs at an expected rate, leading to predictable outcomes.
Pharmacogenetics testing identifies your metabolizer status for specific enzymes, helping doctors select medications and dosages that align with your genetic makeup. For ADHD, this can help your doctor choose a better starting point for some medications, such as atomoxetine, whose dosing CPIC guidelines link to CYP2D6. Dose adjustments based on your response are still part of treatment.
What happens in the lab during a pharmacogenetics test
Once your sample arrives, the lab pulls DNA out of the cells on the swab. It then checks specific spots in each gene where known variants are found. These variants are what make an enzyme work normally, faster, slower or not at all.
Each gene version is given a name called a star allele, such as CYP2D6*1 or CYP2D6*4. The international catalog of these names is kept by PharmVar. Since you inherit one copy of each gene from each parent, your result lists two star alleles for most genes.
Some genes need extra steps. CYP2D6, for example, can be missing entirely or present in extra copies. A good pharmacogenetics test looks for these copy changes, because an extra working copy can turn someone into an ultrarapid metabolizer.
The final step is translation. The lab converts your two alleles into a plain category that prescribers use, and then matches that category to published guidance for each medicine. That is the part of the report you and your prescriber will actually read.
How a cheek swab DNA test is collected
A cheek swab DNA test is one of the easiest medical tests you can do. There are no needles, and children usually tolerate it well. The DNA in the cells lining your cheek is the same DNA found in your blood, so the result is just as meaningful.
- Read the kit instructions fully before you start.
- Wash your hands and open the swab without touching the tip.
- Rub the swab firmly on the inside of the cheek for the time the instructions give.
- Let it dry if instructed, seal it in the tube and label it.
- Pack it in the prepaid mailer and send it back promptly.
The most common problems are too little material on the swab or a mislabeled tube, and both are easy to avoid by following each step. If you are curious how swabs compare with spit tubes, see our guide to cheek swab vs saliva testing.
The RPh Labs at-home kit uses a cheek swab DNA test and includes free shipping both ways. It ships within one business day of your order.
Understanding your metabolizer status
Your metabolizer status describes how active an enzyme is likely to be based on your genes. Most reports use five standard labels, the same terms used in CPIC guidelines:
- Poor metabolizer: little or no enzyme activity.
- Intermediate metabolizer: reduced activity.
- Normal metabolizer: expected activity.
- Rapid metabolizer: somewhat increased activity, a label used for CYP2C19.
- Ultrarapid metabolizer: much higher activity.
What your metabolizer status means depends on the drug. For most medicines, the enzyme turns an active drug into an inactive one, so poor metabolizers build up higher levels. For prodrugs, the enzyme does the opposite. Codeine and tramadol need CYP2D6 to become active, so poor metabolizers may get little pain relief, while ultrarapid metabolizers can get too much of the active form.
For ADHD, the clearest example is atomoxetine. A CYP2D6 poor metabolizer reaches much higher levels than a normal metabolizer on the same dose. You can read more about one specific category in our article on the CYP2C19 rapid metabolizer.
How to read PGx test results for ADHD medicines
PGx test results usually come in two parts. The first is a gene summary that shows each gene, your two star alleles and your metabolizer status. The second is a medication section that groups drugs by whether your genes suggest standard use, extra caution or a possible alternative.
When you look at the ADHD part of your PGx test results, keep these points in mind:
- Atomoxetine and viloxazine rely heavily on CYP2D6, so these are where a result is most likely to matter.
- Amphetamine products are partly cleared by CYP2D6, so the effect is usually smaller.
- Methylphenidate is broken down mainly by CES1, a gene not included on most panels.
- Guanfacine is more sensitive to other drugs that change CYP3A4 than to your genes.
A “use caution” flag does not mean a medicine is forbidden. It means your prescriber may want to start with a different dose, monitor more closely or consider another option. Never stop or change a medicine on your own because of a report.
RPh Labs reports are reviewed by a PharmD pharmacist, and a free pharmacist consultation is included to walk you through your PGx test results before you meet your prescriber.
ADHD and depression: why the whole report matters
ADHD and depression often occur together, and anxiety is common as well. That means many people with ADHD also take, or will one day take, an antidepressant. For these medicines, a pharmacogenetics test can be even more informative than it is for stimulants.
- CYP2C19 affects citalopram, escitalopram and sertraline.
- CYP2D6 affects many antidepressants, including paroxetine, fluoxetine and several older tricyclics.
- Bupropion, used for depression and sometimes off-label for ADHD, is processed partly by CYP2B6.
There is an important twist when treating ADHD and depression together. Fluoxetine, paroxetine and bupropion strongly block CYP2D6. Someone who is a normal metabolizer on paper can act like a poor metabolizer while taking one of these, which can raise levels of atomoxetine. This effect is called phenoconversion.
For more background, see the NIMH page on depression and our guide to genetic testing for antidepressants.
What a pharmacogenetics test cannot tell you
Knowing the limits helps you use your results well. A pharmacogenetics test answers a narrow question: how your genes are likely to affect the way certain drugs are handled. It does not answer everything.
- It does not diagnose ADHD, depression or any other condition.
- It cannot promise that a medicine will work or will be free of side effects.
- It does not measure the effect of other drugs, food, alcohol, smoking or liver and kidney health.
- It does not test every gene that affects every drug. Dopamine-related genes, for example, are still research markers without guideline support.
- It does not replace follow-up visits, symptom tracking or dose adjustments.
Your genes stay the same for life, but the rest of your health does not. Age, new diagnoses and new medicines can all change how a drug behaves. That is why your prescriber treats the report as one input among many rather than a final answer.
A practical way to use the report is to keep a simple medicine diary for the first few weeks of any new ADHD treatment. Note the dose, the time you took it, sleep, appetite and how focused you felt. When you bring that diary and your report to a follow-up visit, your prescriber can see whether the pattern fits what your genes predict or points to something else, such as timing, another medicine or a dose that needs adjusting.
Quality checks to look for in a PGx lab
Not all tests are built the same. Before you order, look for a few signs of quality:
- CLIA certification, which means the lab meets federal standards for clinical testing.
- Independent accreditation, such as COLA or CAP.
- A published gene list so you know exactly what is tested.
- Guideline-based interpretation tied to groups such as CPIC and FDA labeling.
- Clinical review of each report by a qualified professional.
- Report updates when guidelines change.
RPh Labs is a CLIA-certified (CLIA ID 45D2288954) and COLA-accredited (COLA ID 33822) laboratory in Dallas, Texas. Our panel covers 20 genes reported against more than 240 medications, every report is reviewed by a PharmD pharmacist, and reports are updated when guidelines change. You can learn more on our how it works page.
Cost, coverage and turnaround for a pharmacogenetics test
The self-pay price for the RPh Labs pharmacogenetics test is $299. It is HSA and FSA eligible and can be split into 4 interest-free installments. We also accept insurance, including Medicare, Texas Medicaid (TMHP) and Blue Cross Blue Shield of Texas, and we serve patients in 45 states.
Results are ready 7 to 10 business days after your sample reaches the lab. Because your genes do not change, most people only need to test once, and the same report can guide decisions about many future medicines.
For a closer look at pricing across the market, read our guide to pharmacogenetic testing cost. To check your plan, visit our insurance page or call (888) 383-2181.
Conclusion:
PGx test analyzes your genes to show how your body may respond to certain medications. Pharmacogenetics testing can benefit ADHD treatment by reducing some of the guesswork involved in prescribing medications. With insights into how your body processes different drugs, your healthcare provider can create a tailored treatment plan that may improve outcomes, reduce side effects, and speed up the path to effective management of ADHD.
If you or a loved one is dealing with ADHD and struggling to find the right medication, consider undergoing a pharmacogenetics test for a more personalized approach to treatment.
References:
Pharmacogenetics test FAQ
Is a cheek swab DNA test as accurate as a blood test?
For inherited genes, yes. The cells on the inside of your cheek carry the same DNA as your blood cells. What matters most is collecting enough material and following the kit instructions, so the lab has a good sample to work with.
Can my metabolizer status change over time?
Your genes do not change, so your genetic metabolizer status stays the same for life. However, some drugs can slow an enzyme while you take them. For example, fluoxetine, paroxetine and bupropion strongly block CYP2D6, so your prescriber considers your full medicine list when reading your report.
Who should see my PGx test results?
Share them with every prescriber, including your psychiatrist, primary care doctor and any specialists, and with your pharmacist. The results apply to many drug classes beyond ADHD, such as antidepressants, pain relievers and heart medicines, so everyone who prescribes for you can benefit.
Does a pharmacogenetics test help if I have ADHD and depression?
It often adds useful detail. Many antidepressants are affected by CYP2C19 or CYP2D6, and some of them block CYP2D6, which can affect atomoxetine. Your prescriber can use the report to plan both treatments together, alongside your symptoms and history.
Can children take a pharmacogenetics test?
Yes. The genes involved are present from birth, and a cheek swab is painless, so children can be tested. A parent or guardian orders the test and shares the results with the child’s pediatrician or psychiatrist, who makes all medication decisions.
Leave a Reply